Thank you for joining our @NEJM discussion on the recently published study entitled, “Adnexanet alfa for the reversal of factor Xa inhibitor activity.” I would like to thank Dr. Crowther for joining us to discuss this article, as well as all of our expert panelists.
I would like to begin our discussion by asking Dr. Crowther, and our expert panel, a general question: Why is it important to have an antidote for the direct, oral anticoagulants? More specifically, why is this preferable to a factor replacement approach (PCC, etc)?
Perhaps you could also comment on the bleeding risk of the direct, oral anticoagulants relative to warfarin, as well as the importance of the relatively short half-life of these agents.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.